Document Detail

Antiretroviral prophylaxis for breastfeeding transmission in Malawi: drug concentrations, virological efficacy and safety.
MedLine Citation:
PMID:  22910456     Owner:  NLM     Status:  Publisher    
BACKGROUND: Limited information is available on antiretroviral concentrations in women/infant pairs receiving prophylaxis for breastfeeding transmission of HIV and on the relationship between drug levels and the virological and haematochemistry parameters. METHODS: Patient population included HIV-positive pregnant women receiving antiretroviral prophylaxis from gestational week 25 until 6 months after delivery and their breastfed infants. Blood and breast milk samples were collected at delivery, and at months 1, 3 and 6 postpartum. Drug concentrations were measured by liquid chromatography-mass spectrometry. RESULTS: Overall, 66 women were studied: 29 received zidovudine (ZDV), lamivudine (3TC) and nevirapine (NVP), 28 stavudine (d4T), 3TC and NVP, and 9 ZDV, 3TC and lopinavir/ritonavir (LPV/r). Women who received >9 weeks of pre-partum prophylaxis were significantly more likely to have an undetectable viral load both in plasma and in breast milk at delivery. No emergence of resistance mutations was observed in breast milk. Breast milk/plasma concentration ratios were 0.6 for ZDV, 3TC and NVP, 1.0 for d4T and 0.4 for LPV/r. Only NVP reached significant levels in the infants. No correlation with any adverse events, including infant anaemia, was observed with drug concentrations. Two infants who acquired HIV infection had non-nucleoside reverse transcriptase inhibitor mutations at month 6. CONCLUSIONS: Maternal administration of these three regimens up to 6 months postpartum was effective and safe for both mothers and infants. No significant correlation was found between drug concentrations and infant haematological parameters, supporting the hypothesis that other factors may contribute to the development of anaemia in these settings.
Leonardo Palombi; Maria F Pirillo; Mauro Andreotti; Giuseppe Liotta; Fulvio Erba; Jean-Baptiste Sagno; Martin Maulidi; Susanna Ceffa; Haswell Jere; Emilia Marchei; Simona Pichini; Clementina M Galluzzo; Maria C Marazzi; Stefano Vella; Marina Giuliano
Related Documents :
9502606 - A longitudinal investigation of igg and igm antibody responses to the merozoite surface...
3357716 - Outbreak of echovirus 11 infection in hospitalized neonates.
3056946 - Skeletal infection by group b beta-haemolytic streptococci in neonates. a case report a...
6701596 - Subacute salicylate intoxication in an infant with echovirus type 11 infection.
324406 - Persistent ductus arteriosus complicating the respiratory distress syndrome.
11717216 - Inspired co(2) and o(2) in sleeping infants rebreathing from bedding: relevance for sud...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-21
Journal Detail:
Title:  Antiviral therapy     Volume:  -     ISSN:  2040-2058     ISO Abbreviation:  Antivir. Ther. (Lond.)     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9815705     Medline TA:  Antivir Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Public Health, University of Tor Vergata, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Antimicrobial susceptibility of Pseudomonas aeruginosa in China: a review of two multicentre surveil...
Next Document:  The role of histone acetylation in cocaine-induced neural plasticity and behavior.